• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年医学实践中的轻度认知障碍:患者导向、诊断、治疗与伦理

[Mild cognitive impairment in geriatric practice: patient orientation, diagnostics, treatment and ethics].

作者信息

Frölich Lutz, von Arnim Christine, Bohlken Jens, Pantel Johannes, Peters Oliver, Förstl Hans

机构信息

Abteilung Gerontopsychiatrie, Zentralinstitut für Seelische Gesundheit, 68163, Mannheim, Deutschland.

Klinik für Geriatrie, Universitätmedizin Göttingen, Göttingen, Deutschland.

出版信息

Z Gerontol Geriatr. 2023 Oct;56(6):492-497. doi: 10.1007/s00391-022-02098-4. Epub 2022 Aug 25.

DOI:10.1007/s00391-022-02098-4
PMID:36006476
Abstract

Mild cognitive impairment (MCI) is a common problem in old people, which can be distressing for patients and their families. The main feature of MCI is a decrease in cognitive performance with activities of daily living still unimpaired. The identification of treatable risk factors, recognition of early cognitive changes and a timely differential diagnosis, comprehensive information and counselling are important tasks in geriatric medicine. The aim of this article is to present practical recommendations to support physicians working with geriatric patients in recognizing cognitive deficits at an early stage, provide high-quality care focusing on counselling, treatment, and comorbidity management and to maximize the potential of the available treatment options.

摘要

轻度认知障碍(MCI)是老年人常见的问题,这可能会让患者及其家人感到苦恼。MCI的主要特征是认知功能下降,但日常生活活动仍未受损。识别可治疗的风险因素、认识早期认知变化并及时进行鉴别诊断、提供全面信息和咨询是老年医学中的重要任务。本文的目的是提出实用建议,以支持从事老年患者工作的医生在早期识别认知缺陷,提供以咨询、治疗和合并症管理为重点的高质量护理,并最大限度地发挥现有治疗方案的潜力。

相似文献

1
[Mild cognitive impairment in geriatric practice: patient orientation, diagnostics, treatment and ethics].老年医学实践中的轻度认知障碍:患者导向、诊断、治疗与伦理
Z Gerontol Geriatr. 2023 Oct;56(6):492-497. doi: 10.1007/s00391-022-02098-4. Epub 2022 Aug 25.
2
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.痴呆和轻度认知障碍患者的抑郁和焦虑的心理治疗。
Cochrane Database Syst Rev. 2022 Apr 25;4(4):CD009125. doi: 10.1002/14651858.CD009125.pub3.
3
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
4
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
5
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
6
Cognitive stimulation to improve cognitive functioning in people with dementia.认知刺激以改善痴呆症患者的认知功能。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD005562. doi: 10.1002/14651858.CD005562.pub2.
7
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5.
8
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
9
Folic acid with or without vitamin B12 for cognition and dementia.叶酸联合或不联合维生素B12对认知及痴呆的影响
Cochrane Database Syst Rev. 2003(4):CD004514. doi: 10.1002/14651858.CD004514.
10
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.

本文引用的文献

1
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis.实用建议以实现及时、准确诊断症状性阿尔茨海默病(MCI 和痴呆):综述与综合。
J Intern Med. 2021 Aug;290(2):310-334. doi: 10.1111/joim.13244. Epub 2021 Mar 31.
2
European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment.欧洲神经病学会/欧洲阿尔茨海默病联合会关于轻度认知障碍患者的诊断披露、生物标志物咨询和管理的立场声明。
Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.
3
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
《痴呆症的预防、干预与照护:柳叶刀委员会2020年报告》
Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30.
4
[Prevention of stroke and dementia in general practice: evaluation of the project INVADE].[全科医疗中中风和痴呆症的预防:INVADE项目评估]
Dtsch Med Wochenschr. 2020 Jun;145(12):e61-e70. doi: 10.1055/a-1124-9124. Epub 2020 Apr 16.
5
Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.老年人认知障碍筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2020 Feb 25;323(8):764-785. doi: 10.1001/jama.2019.22258.
6
Management of mild cognitive impairment (MCI): The need for national and international guidelines.轻度认知障碍(MCI)的管理:需要国家和国际指南。
World J Biol Psychiatry. 2020 Oct;21(8):579-594. doi: 10.1080/15622975.2019.1696473. Epub 2020 Feb 5.
7
The characterisation of subjective cognitive decline.主观认知下降的特征。
Lancet Neurol. 2020 Mar;19(3):271-278. doi: 10.1016/S1474-4422(19)30368-0. Epub 2020 Jan 17.
8
[Prevalence Rates of Mild Cognitive Impairment and of Dementia in the German Outpatient Health Care Sector 2009-2016].[2009 - 2016年德国门诊医疗保健部门轻度认知障碍和痴呆症的患病率]
Psychiatr Prax. 2020 Jan;47(1):16-21. doi: 10.1055/a-1012-9502. Epub 2019 Oct 31.
9
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study.基于生物标志物的轻度认知障碍患者预后预测(ABIDE):一项建模研究。
Lancet Neurol. 2019 Nov;18(11):1034-1044. doi: 10.1016/S1474-4422(19)30283-2. Epub 2019 Sep 13.
10
An anticholinergic burden score for German prescribers: score development.德国开方医生的抗胆碱能药物负担评分:评分制定。
BMC Geriatr. 2018 Oct 11;18(1):239. doi: 10.1186/s12877-018-0929-6.